Sai Life Sciences544306Pharmaceuticals, contract research
Analyst suggested viewer could consider booking profits on Sai Life Sciences, though no standalone coverage available for formal recommendation
- Viewer holding price
- 549 rupees
- Shares held
- 37 shares
Heard on business television between 14:06:43 - 14:09:43 IST.
- Viewer holding 37 shares at 549 rupees, making profit, asked whether to hold or sell.
- Analyst said booking profit is an art and depends on investor's target returns.
- No standalone coverage on the stock so no formal buy/sell/hold given.
- Noted stock has performed very well.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Sai Life Sciences
Board Meeting on 5 November 2026 to Approve Q2 and H1 FY27 Unaudited Results
1 Oct 2026
Sai Life Sciences CFO discussed the company's shift from near-zero Big Pharma exposure in FY20 to 40% today in its discovery business, and rising China Plus One-driven diversification by large pharma to India
30 Sep 2026
Source: Live TV News Channel · 12 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.